Agents that are known to modulate microglia and macrophages, including minocycline and the GLP-1R agonist exendin-4, inhibited inner blood-retinal barrier breakdown after retinal ischemia-reperfusion [25, 54]. Here, GLP1R is linked to retinal ischemia.